🇮🇱 Ga-68-DOTATOC in Israel

Ga-68-DOTATOC (EDOTREOTIDE) regulatory status in Israel.

Marketing authorisation

MOH

  • Marketing authorisation holder: UIHC PET IMAGING
  • Status: likely_approved

Ga-68-DOTATOC in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Israel

Frequently asked questions

Is Ga-68-DOTATOC approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Ga-68-DOTATOC in Israel?

UIHC PET IMAGING holds the Israeli marketing authorisation.